On this note, immunohistochemistry (IHC) revealed that TPC2 KO tumours exhibited significantly elevated MHC-I levels and significantly reduced PD-L1 expression compared to WT tumours (Figures 3A, B). This evidence concerns the gene CD274 and neoplasm.